EQS-CMS: SCHOTT Pharma AG & Co. KGaA: Release of the Home Member State according to Article 5 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


Werte in diesem Artikel
Aktien

20.05 EUR -0.15 EUR -0.74 %

EQS Post-admission Duties announcement: SCHOTT Pharma AG & Co. KGaA / Home Member State
SCHOTT Pharma AG & Co. KGaA: Release of the Home Member State according to Article 5 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

29.09.2023 / 15:22 CET/CEST
Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Werbung


SCHOTT Pharma AG & Co. KGaA announces according to Art. 5 WpHG that Germany is the Home Member State.


29.09.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany

 
End of News EQS News Service

Werbung

1738411  29.09.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1738411&application_name=news&site_id=smarthouse

Aktuelle SCHOTT Pharma Aktie News

Werbung

SCHOTT Pharma Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für SCHOTT Pharma nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
08:41 SCHOTT Pharma Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
09.07.26 SCHOTT Pharma Kaufen DZ BANK
09.07.26 SCHOTT Pharma Buy Deutsche Bank AG
09.07.26 SCHOTT Pharma Hold Jefferies & Company Inc.
09.07.26 SCHOTT Pharma Outperform RBC Capital Markets